JP2024512497A5 - - Google Patents
Info
- Publication number
- JP2024512497A5 JP2024512497A5 JP2023557369A JP2023557369A JP2024512497A5 JP 2024512497 A5 JP2024512497 A5 JP 2024512497A5 JP 2023557369 A JP2023557369 A JP 2023557369A JP 2023557369 A JP2023557369 A JP 2023557369A JP 2024512497 A5 JP2024512497 A5 JP 2024512497A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- independently selected
- compound according
- sulfur
- nitrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162487P | 2021-03-17 | 2021-03-17 | |
| US63/162,487 | 2021-03-17 | ||
| PCT/US2022/020491 WO2022197763A1 (en) | 2021-03-17 | 2022-03-16 | Inhibitors of plasma kallikrein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512497A JP2024512497A (ja) | 2024-03-19 |
| JP2024512497A5 true JP2024512497A5 (enExample) | 2025-03-24 |
Family
ID=81326196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557369A Pending JP2024512497A (ja) | 2021-03-17 | 2022-03-16 | 血漿カリクレインの阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240226106A1 (enExample) |
| EP (1) | EP4308229A1 (enExample) |
| JP (1) | JP2024512497A (enExample) |
| CN (1) | CN117396469A (enExample) |
| WO (1) | WO2022197763A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3765459A1 (en) | 2018-03-13 | 2021-01-20 | Shire Human Genetic Therapies, Inc. | Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof |
| EP4031245A1 (en) | 2019-09-18 | 2022-07-27 | Takeda Pharmaceutical Company Limited | Heteroaryl plasma kallikrein inhibitors |
| DK4031547T3 (da) | 2019-09-18 | 2024-09-09 | Takeda Pharmaceuticals Co | Plasmakallikreininhibitorer og anvendelser deraf |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| JP2003509428A (ja) * | 1999-09-17 | 2003-03-11 | アボツト・ゲー・エム・ベー・ハー・ウント・コンパニー・カーゲー | 治療薬としてのピラゾロピリミジン |
| CN1486302A (zh) * | 2000-12-07 | 2004-03-31 | CV���ƹ�˾ | 作为抗冠状动脉疾病或动脉硬化的abca-1加强化合物的取代1,3,5-三嗪和嘧啶 |
| TW201103904A (en) * | 2009-06-11 | 2011-02-01 | Hoffmann La Roche | Janus kinase inhibitor compounds and methods |
| WO2014074715A1 (en) * | 2012-11-07 | 2014-05-15 | Genentech, Inc. | Cyclopropyl amide derivatives |
| ES2693718T3 (es) * | 2013-11-06 | 2018-12-13 | Bristol-Myers Squibb Company | Derivados de piridina sustituidos útiles como inhibidores de GSK-3 |
| EP3134408B1 (en) * | 2014-04-22 | 2020-08-12 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| ES2735924T3 (es) * | 2015-04-17 | 2019-12-20 | Dow Agrosciences Llc | Moléculas que tienen utilidad plaguicida e intermediarios, composiciones y procesos, relacionados con ellas |
| JP6629958B2 (ja) * | 2015-07-29 | 2020-01-15 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | アルキルまたはシクロアルキルＰ２’基を担持する大員環の第ＸＩａ因子阻害剤 |
| EP3601259B1 (en) * | 2017-03-30 | 2022-02-23 | F. Hoffmann-La Roche AG | Isoquinolines as inhibitors of hpk1 |
| AU2018244935A1 (en) * | 2017-03-30 | 2019-08-15 | F. Hoffmann-La Roche Ag | Naphthyridines as inhibitors of HPK1 |
| EA202091269A1 (ru) * | 2017-11-21 | 2020-08-07 | Бристол-Маерс Сквибб Компани | Сульфон-, пиридин-, алкил-, амид-замещенные гетероарильные соединения |
| EP3765459A1 (en) | 2018-03-13 | 2021-01-20 | Shire Human Genetic Therapies, Inc. | Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof |
| TW202116753A (zh) * | 2019-07-11 | 2021-05-01 | 大陸商南京征祥醫藥有限公司 | 以噌啉作為hpk1的抑制劑 |
| CN114573575B (zh) * | 2020-04-28 | 2023-08-04 | 江南大学 | 一类含氧五元杂环化合物、合成方法、药物组合物及用途 |
-
2022
- 2022-03-16 JP JP2023557369A patent/JP2024512497A/ja active Pending
- 2022-03-16 CN CN202280033915.5A patent/CN117396469A/zh active Pending
- 2022-03-16 WO PCT/US2022/020491 patent/WO2022197763A1/en not_active Ceased
- 2022-03-16 US US18/550,504 patent/US20240226106A1/en active Pending
- 2022-03-16 EP EP22714697.4A patent/EP4308229A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024512497A5 (enExample) | ||
| JP2024516073A5 (enExample) | ||
| JP2024510503A5 (enExample) | ||
| JP2022548696A5 (enExample) | ||
| JP2024510504A5 (enExample) | ||
| US6649647B1 (en) | Trioxane derivatives | |
| JP2019013227A5 (enExample) | ||
| JP2022141692A5 (enExample) | ||
| JP2018536634A5 (enExample) | ||
| JP2024510502A5 (enExample) | ||
| WO2017001307A1 (en) | Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection | |
| WO2015151490A1 (ja) | 新規な三環性キノン誘導体 | |
| JP2016513112A5 (enExample) | ||
| JP2015532295A5 (enExample) | ||
| JP2015516389A5 (enExample) | ||
| WO2018111315A1 (en) | PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES | |
| EA020885B1 (ru) | Ингибиторы протеинкиназы и их применение | |
| CA3063938A1 (en) | Compounds, compositions and methods | |
| CN1401646A (zh) | 一种杀虫化合物及生产方法 | |
| JP2008508365A5 (enExample) | ||
| CN1125048C (zh) | 生产异脲的方法 | |
| JP2024522201A5 (enExample) | ||
| JPH0225416A (ja) | セロトニン拮抗薬の改良 | |
| JP2022505827A (ja) | 置換インドール二量体の化合物 | |
| CN112142716B (zh) | 一种5元杂芳基取代的吡嗪衍生物及其应用 |